1-3 of 3
Liesbeth E.M. Suijk
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Improved T-Cell Chimerism and Successful Withdrawal of Immunosuppression after Non-Myeloablative Stem Cell Transplantation for Sickle Cell Disease with Azathioprine/Hydroxyurea Preconditioning Added to Alemtuzumab/TBI Conditioning

Elisabeth Dovern, Mesire Aydin, Man Wai Tang, Liesbeth E.M. Suijk, Gerianne M. Hoogendoorn, Charlotte F.J. Van Tuijn, Jean-Louis Kerkhoffs, Caroline E. Rutten, Sacha S. Zeerleder, Mette D. Hazenberg, Bart J. Biemond, Erfan Nur
Journal: Blood
Blood (2022) 140 (Supplement 1): 10476–10477.
https://doi.org/10.1182/blood-2022-159390
Published: 2022
Journal Articles

Quality of Life and Personal Life Goals of Adult Sickle Cell Disease Patients after Curative Allogeneic Stem Cell Transplantation: A Mixed Methods Study

Elisabeth Dovern, Sterre J.A.M. Nijland, Maud M. Van Muilekom, Liesbeth E.M. Suijk, Hilda Mekelenkamp, Bart J. Biemond, Lotte Haverman, Erfan Nur
Journal: Blood
Blood (2022) 140 (Supplement 1): 1393–1394.
https://doi.org/10.1182/blood-2022-159406
Published: 2022
Journal Articles

Adding Azathioprine and Hydroxyurea Preconditioning to Alemtuzumab/TBI May Improve Donor Chimerism in Matched Sibling Donor Allogeneic Stem Cell Transplantation in Adult Sickle Cell Patients

Erfan Nur, MD PhD, Sacha S Zeerleder, MD PhD, Aafke E. Gaartman, MD, Caroline E Rutten, MD PhD, Charlotte F.J. Van Tuijn, MPH, PhD, Liesbeth E.M. Suijk, Mette D Hazenberg, MD PhD, Bart J. Biemond, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 997.
https://doi.org/10.1182/blood-2019-129403
Published: 2019